We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Ooma
OOMA
$588M
| $325K | ﹤0.01% |
23,414
+7,964
| +52% | +$116K |
|
|
BLMT
2502
DELISTED
BSB Bancorp, Inc.
BLMT
| $325K | ﹤0.01% |
11,584
+3,697
| +47% | +$110K |
|
2503
Altisource Portfolio Solutions
ASPS
$66M
| $324K | ﹤0.01% |
1,803
+543
| +43% | +$109K |
|
|
RBNC
2504
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $324K | ﹤0.01% |
14,065
+4,454
| +46% | +$104K |
|
|
NVTR
2505
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $324K | ﹤0.01% |
19,823
+7,275
| +58% | +$139K |
|
2506
TG Therapeutics
TGTX
$7.59B
| $323K | ﹤0.01% |
78,898
+26,880
| +52% | +$134K |
|
2507
Yeti Holdings
YETI
$3.93B
| $323K | ﹤0.01% |
+21,741
| New | +$345K |
|
|
EGIO
2508
DELISTED
Edgio, Inc. Common Stock
EGIO
| $323K | ﹤0.01% |
3,449
+1,161
| +51% | +$170K |
|
2509
Immersion
IMMR
$246M
| $321K | ﹤0.01% |
35,811
+10,316
| +40% | +$96.4K |
|
2510
Energy Fuels
UUUU
$3.22B
| $320K | ﹤0.01% |
112,304
+39,396
| +54% | +$127K |
|
|
ALBO
2511
DELISTED
Albireo Pharma Inc
ALBO
| $320K | ﹤0.01% |
13,056
+3,743
| +40% | +$98.9K |
|
|
PES
2512
DELISTED
Pioneer Energy Services Corp.
PES
| $320K | ﹤0.01% |
260,073
+67,845
| +35% | +$169K |
|
2513
Civista Bancshares
CIVB
$596M
| $317K | ﹤0.01% |
18,226
+6,379
| +54% | +$135K |
|
2514
Energy Recovery
ERII
$450M
| $317K | ﹤0.01% |
47,105
+14,838
| +46% | +$117K |
|
2515
Impinj
PI
$5.25B
| $317K | ﹤0.01% |
21,755
+6,684
| +44% | +$131K |
|
|
EGLE
2516
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $317K | ﹤0.01% |
9,808
+2,937
| +43% | +$99.6K |
|
|
REVG
2517
DELISTED
REV Group
REVG
| $316K | ﹤0.01% |
42,129
+12,687
| +43% | +$144K |
|
2518
AMES National
ATLO
$278M
| $315K | ﹤0.01% |
12,407
+3,863
| +45% | +$105K |
|
2519
Graham Corp
GHM
$1.23B
| $315K | ﹤0.01% |
13,778
+4,277
| +45% | +$106K |
|
2520
NWPX Infrastructure Inc
NWPX
$1.14B
| $315K | ﹤0.01% |
+13,520
| New | +$288K |
|
|
ACHN
2521
DELISTED
Achillion Pharmaceuticals
ACHN
| $315K | ﹤0.01% |
198,304
+59,114
| +42% | +$167K |
|
|
DFRG
2522
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $315K | ﹤0.01% |
44,035
+16,317
| +59% | +$115K |
|
2523
Southern First Bancshares
SFST
$604M
| $314K | ﹤0.01% |
9,787
+2,961
| +43% | +$106K |
|
|
DS
2524
DELISTED
Drive Shack Inc.
DS
| $314K | ﹤0.01% |
80,033
+25,332
| +46% | +$125K |
|
2525
RGC Resources
RGCO
$228M
| $312K | ﹤0.01% |
+10,422
| New | +$289K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.